Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

A mitogen-activated protein kinase kinase inhibitor induced compound skin toxicity with oedema in metastatic malignant melanoma.

Thomas, C L; Mortimer, P S; Larkin, J M; Basu, T N; Gore, M E; Fearfield, L.

Clin Exp Dermatol ; 41(3): 267-71, 2016 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-26411345

2.

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma.

Gore, M E; Szczylik, C; Porta, C; Bracarda, S; Bjarnason, G A; Oudard, S; Lee, S-H; Haanen, J; Castellano, D; Vrdoljak, E; Schöffski, P; Mainwaring, P; Hawkins, R E; Crinò, L; Kim, T M; Carteni, G; Eberhardt, W E E; Zhang, K; Fly, K; Matczak, E; Lechuga, M J; Hariharan, S; Bukowski, R.

Br J Cancer ; 113(1): 12-9, 2015 Jun 30.

Artigo em Inglês | MEDLINE | ID: mdl-26086878

3.

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma.

Hutson, T E; Bukowski, R M; Rini, B I; Gore, M E; Larkin, J M; Figlin, R A; Barrios, C H; Escudier, B; Lin, X; Fly, K; Martell, B; Matczak, E; Motzer, R J.

Br J Cancer ; 110(5): 1125-32, 2014 Mar 04.

Artigo em Inglês | MEDLINE | ID: mdl-24434434

4.

A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer.

Glasspool, R M; Brown, R; Gore, M E; Rustin, G J S; McNeish, I A; Wilson, R H; Pledge, S; Paul, J; Mackean, M; Hall, G D; Gabra, H; Halford, S E R; Walker, J; Appleton, K; Ullah, R; Kaye, S.

Br J Cancer ; 110(8): 1923-9, 2014 Apr 15.

Artigo em Inglês | MEDLINE | ID: mdl-24642620

5.

A study of the decision outcomes and financial costs of multidisciplinary team meetings (MDMs) in oncology.

De Ieso, P B; Coward, J I; Letsa, I; Schick, U; Nandhabalan, M; Frentzas, S; Gore, M E.

Br J Cancer ; 109(9): 2295-300, 2013 Oct 29.

Artigo em Inglês | MEDLINE | ID: mdl-24084764

6.

Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma.

Motzer, R J; Escudier, B; Bukowski, R; Rini, B I; Hutson, T E; Barrios, C H; Lin, X; Fly, K; Matczak, E; Gore, M E.

Br J Cancer ; 108(12): 2470-7, 2013 Jun 25.

Artigo em Inglês | MEDLINE | ID: mdl-23695024

7.

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

Calvert, A H; Newell, D R; Gumbrell, L A; O'Reilly, S; Burnell, M; Boxall, F E; Siddik, Z H; Judson, I R; Gore, M E; Wiltshaw, E.

J Clin Oncol ; 41(28): 4453-4454, 2023 Oct 01.

Artigo em Inglês | MEDLINE | ID: mdl-37757592

8.

Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities.

Sinha, R; Edmonds, K; Newton-Bishop, J A; Gore, M E; Larkin, J; Fearfield, L.

Br J Dermatol ; 167(5): 987-94, 2012 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-22913467

9.

Outcomes of surgical management of bowel obstruction in relapsed epithelial ovarian cancer (EOC).

Kolomainen, D F; Daponte, A; Barton, D P J; Pennert, K; Ind, T E J; Bridges, J E; Shepherd, J H; Gore, M E; Kaye, S B; Riley, J.

Gynecol Oncol ; 125(1): 31-6, 2012 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-22082991

10.

Challenges and opportunities for converting renal cell carcinoma into a chronic disease with targeted therapies.

Gore, M E; Larkin, J M G.

Br J Cancer ; 104(3): 399-406, 2011 Feb 01.

Artigo em Inglês | MEDLINE | ID: mdl-21285971

11.

Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies.

Eisen, T; Marais, R; Affolter, A; Lorigan, P; Robert, C; Corrie, P; Ottensmeier, C; Chevreau, C; Chao, D; Nathan, P D; Jouary, T; Harries, M; Negrier, S; Montegriffo, E; Ahmad, T; Gibbens, I; James, M G; Strauss, U P; Prendergast, S; Gore, M E.

Br J Cancer ; 105(3): 353-9, 2011 Jul 26.

Artigo em Inglês | MEDLINE | ID: mdl-21750549

12.

A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma.

Br J Cancer ; 105(3): 346-52, 2011 Jul 26.

Artigo em Inglês | MEDLINE | ID: mdl-21750555

13.

A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma.

Larkin, J M G; Ferguson, T R; Pickering, L M; Edmonds, K; James, M G; Thomas, K; Banerji, U; Berns, B; de Boer, C; Gore, M E.

Br J Cancer ; 103(8): 1149-53, 2010 Oct 12.

Artigo em Inglês | MEDLINE | ID: mdl-20842130

14.

A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma.

Ang, J E; Shah, R N; Everard, M; Keyzor, C; Coombes, I; Jenkins, A; Thomas, K; A'Hern, R; Jones, R L; Blake, P; Gabra, H; Hall, G; Gore, M E; Kaye, S B.

Ann Oncol ; 20(11): 1787-93, 2009 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-19542250

15.

The role of human endogenous retroviruses in melanoma.

Singh, S; Kaye, S; Gore, M E; McClure, M O; Bunker, C B.

Br J Dermatol ; 161(6): 1225-31, 2009 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-19785608

16.

Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinoma.

Ross, P J; Teoh, E M; A'hern, R P; Rhys-Evans, P H; Harrington, K J; Nutting, C M; Gore, M E.

Clin Oncol (R Coll Radiol) ; 21(4): 311-4, 2009 May.

Artigo em Inglês | MEDLINE | ID: mdl-19201585

17.

Second primary melanomas on treatment with vemurafenib: reply from the authors.

Fearfield, L; Newton-Bishop, J A; Sinha, R; Edmonds, K; Gore, M E; Larkin, J.

Br J Dermatol ; 168(4): 888-9, 2013 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-23066884

18.

Mucinous ovarian cancer.

Harrison, M L; Jameson, C; Gore, M E.

Int J Gynecol Cancer ; 18(2): 209-14, 2008.

Artigo em Inglês | MEDLINE | ID: mdl-17624989

19.

Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancer.

Bishara, S; Griffin, M; Cargill, A; Bali, A; Gore, M E; Kaye, S B; Shepherd, J H; Van Trappen, P O.

Eur J Obstet Gynecol Reprod Biol ; 138(1): 71-5, 2008 May.

Artigo em Inglês | MEDLINE | ID: mdl-17644243

20.

A novel point mutation in P450c17 (CYP17) causing combined 17alpha-hydroxylase/17,20-lyase deficiency.

Brooke, A M; Taylor, N F; Shepherd, J H; Gore, M E; Ahmad, T; Lin, L; Rumsby, G; Papari-Zareei, M; Auchus, R J; Achermann, J C; Monson, J P.

J Clin Endocrinol Metab ; 91(6): 2428-31, 2006 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-16569739

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: